glp 1 and alzheimer's study Details of failed studies cast pall on Novo Nordisk's GLP-1 as treatment Frontiers | GLP-1 and Underlying

Theres maybe one at a high dose

These trials will investigate the ability of semaglutide and tirzepatide to reduce cardiovascular disease and mortality, potentially expanding evidence of clinical benefit of these therapies and establishing a benchmark for future pharmacotherapies in overweight and obesity

regulators on Monday approved a pill version of the blockbuster weight-loss drug Wegovy, marking the first time a daily oral medication has been green-lit to treat obesity

has been revised to reflect the ongoing implementation of the Inflation Reduction Act of 2022

Papilla preservation flaps for periodontal regeneration of molars severely compromised by combined furcation and intrabony defects: retrospective analysis of a registry-based cohort